David Kong

David CM Kong profile

David CM Kong

Centre for Medicine Use and Safety
Faculty of Pharmacy and Pharmaceutical Sciences

Senior Lecturer

Lab profile
Email: david.kong@monash.edu
Phone: +61 3 9903 9035
Room: 132C

Research in pharmacy and pharmaceutical science will impact the safety and well-being of those who need medicines and also the general community. It is exciting and full of challenges. It is my opportunity to give something back to the society. No action today, no cure tomorrow.

David's research interests are in infectious diseases and mental health. Specifically, his interests include antimicrobial use in residential aged care facilities; pharmacoeconomics and pharmacokinetics of antifungals and antibiotics in lung transplantation and haematology-oncology settings; transmission  modelling of bacterial infection; use of antifungals in fungal eye infections; antimicrobial stewardship; use of sedating medications in acute agitation or behavourial emergency. He is a strong supporter of pharmacy and was awarded the GlaxoSmithKline Medal of Merit in 2013 by the Society of Hospital  Pharmacists of Australia for his contribution to hospital pharmacy spanning academia, research, pharmacy practice, leadership and advocacy.

Recent media items

Alarm over nursing home superbugs
Recognition for pharmacist leading fight against superbugs
Alarm over threat of superbugs in nursing homes due to overprescribed antibiotics
SHPA Medal of Merit awarded to a pharmacist who is leading the fight against superbugs in our hospitals
Super bug threat to aged care, study says

Selected recent publications

Lim CJ, Kwong M, Stuart RL, Buising KL, Friedman ND, Bennett N, Cheng AC, Peleg AY, Marshall C, Kong DCM. Antibiotic Prescribing Practice in Residential Aged Care Facilities - Healthcare Providers' Perspectives. Med J Aust; 201(2): 98-102 (2014).

Lim CJ, Cheng A, KennonJ, Spelman D, Hale D, Melican G, Sidjabat H, Paterson D, Kong DCM, Peleg A. Prevalence of Multidrug-resistant Organisms and Risk Factors for Carriage in Long-term Care Facilities – A Nested Case-Control Study. J Antimicrob Chemother; 69: 1972-1980 (2014).
Chan EW, Taylor DM, Knott J, Phillips G, Castel DJ, Kong DCM.  Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicentre, randomised, double-blind, placebo-controlled clinical trial. Annal Emerg Med; 61: 72-81 (2013).

Heng SC, Slavin M, Al-Badriyeh D, Kirsa S, Seymour J, Grigg A, Thursky K, Bajel A, Nation RL, Kong DCM. Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy. J Antimicrob Chemother; 68(7): 1669-1678 (2013).

Duguid M, Kong DCM. The role of pharmacy service. Invited book chapter. In: Duguid M and Cruickshank M (eds). Antimicrobial Stewardship in Australian Hospitals. Chapter 9: 104 - 111, Pub: The Australian Commission on Quality and Safety in Health Care (2011).